Moderna stock gains 4.5 percent ahead of the open

At the close on September 23, 2026, Moderna stock had gained 4.5 percent, while the Nasdaq Composite fell 0.5 percent. The session followed a fresh 52-week high of USD 192.31.

Moderna stock closed at USD 189.11 on the Nasdaq on September 23, 2026, gaining 4.5 percent. The move contrasted with a 0.5 percent decline in the Nasdaq Composite during the same session.

September 23, 2026 in numbers

Moderna Inc. (ISIN US60770K1079, Nasdaq: MRNA) reached a fresh 52-week high of USD 192.31 during the September 23, 2026 session, according to Stocktwits. GuruFocus reported that Moderna gained 4.5 percent while the Dow and S&P 500 each fell 0.3 percent and the Nasdaq Composite declined 0.5 percent.

Chief Executive Stéphane Bancel said at the Bernstein Insights Healthcare Leaders and Disruptors Forum that Moderna had never been only a COVID-19 vaccine company, as reported by Seeking Alpha. The statement accompanied attention on the company pipeline and helped define the session narrative.

Today, September 24, 2026

Moderna enters the session after the September 23, 2026 close and a USD 192.31 52-week high. A GuruFocus report also said UBS maintained a Neutral rating on September 23, 2026, with a USD 150 price target ahead of Phase III melanoma trial results.